KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) EPS (Basic): 2009-2025

Historic EPS (Basic) for Ionis Pharmaceuticals (IONS) over the last 17 years, with Sep 2025 value amounting to -$0.80.

  • Ionis Pharmaceuticals' EPS (Basic) rose 15.79% to -$0.80 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.61, marking a year-over-year increase of 34.02%. This contributed to the annual value of -$3.04 for FY2024, which is 18.75% down from last year.
  • Ionis Pharmaceuticals' EPS (Basic) amounted to -$0.80 in Q3 2025, which was down 202.56% from $0.78 recorded in Q2 2025.
  • Ionis Pharmaceuticals' EPS (Basic)'s 5-year high stood at $1.59 during Q4 2021, with a 5-year trough of -$1.03 in Q3 2023.
  • In the last 3 years, Ionis Pharmaceuticals' EPS (Basic) had a median value of -$0.80 in 2025 and averaged -$0.60.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' EPS (Basic) tumbled by 1,000.00% in 2024, and later soared by 273.33% in 2025.
  • Quarterly analysis of 5 years shows Ionis Pharmaceuticals' EPS (Basic) stood at $1.59 in 2021, then crashed by 123.27% to -$0.37 in 2022, then spiked by 83.78% to -$0.06 in 2023, then slumped by 1,000.00% to -$0.66 in 2024, then grew by 15.79% to -$0.80 in 2025.
  • Its last three reported values are -$0.80 in Q3 2025, $0.78 for Q2 2025, and -$0.93 during Q1 2025.